Munich Re's Cyber Book Slips to $1.7 Billion While Buybacks and Analyst Targets Diverge

Munich Re's cyber portfolio fell from $2.1B to $1.7B as its At-Bay deal awaits 2027 close; pricing discipline stressed before renewals.

Munich Re used this week's Rendez-Vous de Septembre in Monte Carlo to give the market a candid look at its cyber business — and the picture was not one of expansion. Board member Stefan Golling acknowledged that growth in the segment has flattened, with the group's cyber book contracting from $2.1 billion to $1.7 billion.

The timing is awkward. Munich Re had only recently moved to reinforce its position in that very market through the acquisition of US cyber insurtech At-Bay. That deal, announced for $575 million, is now more than a month old, and completion is not expected until the first quarter of 2027. With the existing cyber portfolio shrinking in the meantime, the question of how the acquisition and organic business will eventually fit together is left hanging.

Pricing discipline takes center stage

Christa Schwimmer, CEO Specialty Reinsurance, used the Monte Carlo platform to stress the importance of pricing discipline ahead of the January 2027 renewal round. Her comments fit a pattern that has accompanied the reinsurance industry for some time: competitive pressure on premiums has mounted over recent years, and the major reinsurers are increasingly signaling a willingness to surrender market share rather than let prices fall below a certain threshold.

Berenberg's analyst had confirmed a "Neutral" rating with a price target of 565 euros on Tuesday, explicitly pointing to sustained pricing pressure in the reinsurance business. That view chimes with the tone coming out of Monte Carlo and offers fresh evidence that the analyst community regards pricing as the central risk for the 2027 financial year.

Buyback program presses ahead regardless

Whatever the debates over cyber growth and pricing discipline, Munich Re is continuing its share repurchase program undeterred. Between August 28 and September 7, the company bought back 413,000 of its own shares, bringing the total volume since the program began on May 14 to 2,071,924 shares. That steady demand from the company's own coffers should lend support to the stock, independent of the operational headlines emerging from Monte Carlo.

The shares have steadied somewhat of late: on Friday the stock closed at 504.80 euros, a gain of 1.4 percent on the day. Over the past seven days, however, the stock is down 4.0 percent, and it has lost 10 percent since the start of the year. A noticeable gap therefore remains to the 52-week high of 575.40 euros, set on October 9, 2025 — the current price sits roughly 12 percent below that peak.

Analysts see room, but not unanimity

Barclays raised its price target for Munich Re from 576 to 598 euros on September 4, reaffirming its "Overweight" or "Buy" rating. Berenberg struck a more cautious note the following day, confirming a "Hold" rating with a target of 565 euros. RBC left its "Sector Perform" assessment unchanged with a target of 500 euros.

The spread of targets between 500 and 598 euros reflects differing views on how reinsurance pricing will develop. While Barclays bets on further upside potential, other houses counsel caution in the face of competitive pressure in the industry. The consensus of 17 firms currently puts the average price target at 549.78 euros, within a range of 480 to 632 euros — a sign that opinions on the road ahead diverge considerably.

A report published in early September, following a strong second quarter, classified Munich Re as still "comfortably on track" toward its annual target. That assessment aligns with the broader picture from recent analyst commentary: despite differing price targets, most houses do not assume a fundamental deterioration in the business.

What to watch next

The next opportunity for the company to counter worries about cyber growth and pricing pressure with hard numbers comes on November 12, with third-quarter 2026 results. Until then, the market is likely to watch closely whether the pricing discipline proclaimed in Monte Carlo actually holds, or whether competitive pressure in the reinsurance business intensifies further. For investors, the central question remains whether the ongoing buybacks and positive analyst voices will be enough to push the stock closer to its annual high — or whether warnings over rising cyber risk, fueled in part by the use of artificial intelligence, will weigh on sentiment. The coming weeks around the renewal negotiations should provide further clarity.